erdosteine
PolandDrugs containing this active substance
-
The medicine is used to facilitate expectoration by reducing the viscosity of secretions. It is recommended for acute and chronic diseases of the upper respiratory tract, bronchi, and lungs, as well as for preventing seasonal exacerbations of chronic bronchitis.
Form: tablets
Active substance Dosage erdosteine 300 mg ATC: R05CB15
Manufacturer: Polfarmex S.A.
-
The medicinal product is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used preventatively during seasonal exacerbations of chronic bronchitis.
Form: powder for preparation of oral suspension
Active substance Dosage erdosteine 35 mg/ml ATC: R05CB15
Manufacturer: Fulton Medicinali S.p.A. Zeta Farmaceutici S.p.A.
-
The medicine is used to treat diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used to prevent seasonal exacerbations of chronic bronchitis.
Form: capsules, hard
Active substance Dosage erdosteine 300 mg ATC: R05CB15
Manufacturer: Angelini Pharma Czech Republic s.r.o.
-
It is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It may also be used preventatively during seasonal exacerbations of chronic bronchitis.
Form: capsules, hard
Active substance Dosage erdosteine 300 mg ATC: R05CB15
Manufacturer: Angelini Pharma Czech Republic s.r.o.
-
The medicinal product is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used to prevent seasonal exacerbations of chronic bronchitis.
Form: capsules, hard
Active substance Dosage erdosteine 300 mg ATC: R05CB15
Manufacturer: Angelini Pharma Czech Republic s.r.o.
-
The medicine is used to thin and facilitate the expectoration of mucus from the respiratory tract. It is used as support in the treatment of inflammation of the nose, sinuses, larynx, trachea, bronchi, and lungs.
Form: powder for preparation of oral suspension
Active substance Dosage erdosteine 225 mg ATC: R05CB15
Manufacturer: Fine Food & Pharmaceuticals NTM S.P.A.
-
The medicine is used to facilitate expectoration and reduce the viscosity of secretions in acute and chronic diseases of the respiratory tract, bronchi, and lungs. It also helps in preventing seasonal exacerbations of chronic bronchitis.
Form: powder for preparation of oral suspension
Active substance Dosage erdosteine 35 mg/ml ATC: R05CB15
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicine is used to treat diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates expectoration. It is also used preventatively during seasonal exacerbations of chronic bronchitis.
Form: tablets
Active substance Dosage erdosteine 300 mg ATC: R05CB15
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicine helps to thin and facilitate the expectoration of mucous secretion from the respiratory tract. It is used as support in the treatment of acute and chronic inflammation of the nose, sinuses, larynx, trachea, bronchi, and lungs.
Form: tablets
Active substance Dosage erdosteine 225 mg ATC: R05CB15
Manufacturer: Mako Pharma Sp. z o.o.